TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.

Source:http://linkedlifedata.com/resource/pubmed/id/17636117

Proc. Natl. Acad. Sci. U.S.A. 2007 Jul 24 104 30 12468-73

Download in:

View as

Triples

General Info

PMID
17636117